{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:28:34Z","timestamp":1792783714256,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T00:00:00Z","timestamp":1772928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NSFC82500209"],"award-info":[{"award-number":["NSFC82500209"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023QH062"],"award-info":[{"award-number":["ZR2023QH062"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Second Qilu Hospital of Shandong University Cultivation Fund","award":["2026RC018"],"award-info":[{"award-number":["2026RC018"]}],"id":[{"id":"https:\/\/ror.org\/056ef9489","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Growing evidence underscores neuroinflammation\u2019s role in Parkinson\u2019s disease (PD), with accumulating evidence suggesting a potential role for peripheral inflammation. The clinical applicability and mechanistic relevance of peripheral inflammatory biomarkers in PD remain to be fully elucidated. We analyzed data from the Parkinson\u2019s Progression Markers Initiative (PPMI), including longitudinal clinical assessments, blood counts, cerebrospinal fluid (CSF) biomarkers, and genetic data. Six peripheral inflammatory indices were derived: neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), systemic inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI). Spearman correlation, multiple linear regression, and generalized estimating equations were employed to examine associations. Unsupervised k-means clustering was performed to identify distinct inflammatory clusters, with differences assessed using ANCOVA analysis. NLR and SII were significantly elevated in PD, with NLR showing the strongest association. Peripheral inflammatory biomarkers showed distinct clinical correlations, with NLR demonstrating associations with both non-motor (cognitive decline, olfactory impairment, and depression,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) and motor symptoms (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). SII, and SIRI showed correlations with motor progression (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), while SII additionally associated with sleepiness disorders (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Cluster analysis identified two distinct inflammatory clusters: a high-inflammation cluster demonstrating significantly worse cognitive function (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.008), olfactory impairment (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), and autonomic dysfunction (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) at baseline, along with accelerated motor (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.038) and cognitive decline (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) during follow-up. This high-inflammation cluster also showed elevated CSF neurodegeneration markers including pTau, tTau, NfL, and GFAP (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Peripheral inflammatory biomarkers show robust associations with clinical features in PD, highlighting their potential as markers associated with disease features and progression, and suggesting a basis for inflammatory-based subgrouping.\n                  <\/jats:p>","DOI":"10.1007\/s10571-026-01708-8","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T02:15:59Z","timestamp":1772936159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Peripheral Inflammatory Biomarkers in Parkinson\u2019s Disease: Clinical Correlations and Stratification"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0329-5871","authenticated-orcid":false,"given":"Guo-Yun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4679-9260","authenticated-orcid":false,"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0156-7717","authenticated-orcid":false,"given":"Jin-Hui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1786-7455","authenticated-orcid":false,"given":"Ling-Xiao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,8]]},"reference":[{"issue":"12","key":"1708_CR1","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1002\/mds.26431","volume":"30","author":"D Berg","year":"2015","unstructured":"Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, Poewe W, Stern M, Deuschl G (2015) MDS research criteria for prodromal Parkinson\u2019s disease. Mov Disord 30(12):1600\u20131611. https:\/\/doi.org\/10.1002\/mds.26431","journal-title":"Mov Disord"},{"key":"1708_CR2","doi-asserted-by":"publisher","first-page":"101681","DOI":"10.1016\/j.arr.2022.101681","volume":"80","author":"SK Beura","year":"2022","unstructured":"Beura SK, Panigrahi AR, Yadav P, Singh SK (2022) Role of platelet in Parkinson\u2019s disease: insights into pathophysiology & theranostic solutions. Ageing Res Rev 80:101681. https:\/\/doi.org\/10.1016\/j.arr.2022.101681","journal-title":"Ageing Res Rev"},{"issue":"761","key":"1708_CR3","doi-asserted-by":"publisher","first-page":"eadm8563","DOI":"10.1126\/scitranslmed.adm8563","volume":"16","author":"S Bido","year":"2024","unstructured":"Bido S, Nannoni M, Muggeo S, Gambare D, Ruffini G, Bellini E, Passeri L, Iaia S, Luoni M, Provinciali M, Giannelli SG, Giannese F, Lazarevic D, Gregori S, Broccoli V (2024) Microglia-specific IL-10 gene delivery inhibits neuroinflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Sci Transl Med 16(761):eadm8563. https:\/\/doi.org\/10.1126\/scitranslmed.adm8563","journal-title":"Sci Transl Med"},{"issue":"5","key":"1708_CR4","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s12264-017-0163-9","volume":"33","author":"L Cen","year":"2017","unstructured":"Cen L, Yang C, Huang S, Zhou M, Tang X, Li K, Guo W, Wu Z, Mo M, Xiao Y, Chen X, Yang X, Huang Q, Chen C, Qu S, Xu P (2017) Peripheral lymphocyte subsets as a marker of Parkinson\u2019s disease in a chinese population. Neurosci Bull 33(5):493\u2013500. https:\/\/doi.org\/10.1007\/s12264-017-0163-9","journal-title":"Neurosci Bull"},{"key":"1708_CR5","doi-asserted-by":"publisher","unstructured":"Craig DW, Hutchins E, Violich I, Alsop E, Gibbs JR, Levy S, Robison M, Prasad N, Foroud T, Crawford KL, Toga AW, Whitsett TG, Kim S, Casey B, Reimer A, Hutten SJ, Frasier M, Kern F, Fehlman T, Keller A, Cookson MR, Van Keuren-Jensen K, Parkinson Progression Marker I (2021) RNA sequencing of whole blood reveals early alterations in immune cells and gene expression in Parkinson\u2019s disease. Nat Aging 1(8):734\u2013747. https:\/\/doi.org\/10.1038\/s43587-021-00088-6","DOI":"10.1038\/s43587-021-00088-6"},{"issue":"5","key":"1708_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00281-022-00943-7","volume":"44","author":"JH DeLong","year":"2022","unstructured":"DeLong JH, Ohashi SN, O\u2019Connor KC, Sansing LH (2022) Inflammatory responses after ischemic stroke. Semin Immunopathol 44(5):625\u2013648. https:\/\/doi.org\/10.1007\/s00281-022-00943-7","journal-title":"Semin Immunopathol"},{"issue":"6","key":"1708_CR7","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.26529","volume":"31","author":"N Dzamko","year":"2016","unstructured":"Dzamko N, Rowe DB, Halliday GM (2016) Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers. Mov Disord 31(6):889\u2013897. https:\/\/doi.org\/10.1002\/mds.26529","journal-title":"Mov Disord"},{"issue":"7","key":"1708_CR8","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","volume":"140","author":"SM Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad SM, Zeighami Y, Dagher A, Postuma RB (2017) Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression. Brain 140(7):1959\u20131976. https:\/\/doi.org\/10.1093\/brain\/awx118","journal-title":"Brain"},{"key":"1708_CR9","doi-asserted-by":"publisher","unstructured":"Folta J, Rzepka Z, Wrzesniok D (2025) The role of inflammation in neurodegenerative diseases: Parkinson\u2019s disease, alzheimer\u2019s disease, and multiple sclerosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26115177","DOI":"10.3390\/ijms26115177"},{"key":"1708_CR10","doi-asserted-by":"publisher","first-page":"16021","DOI":"10.1038\/npjparkd.2016.21","volume":"2","author":"J Freed","year":"2016","unstructured":"Freed J, Chakrabarti L (2016) Defining a role for hemoglobin in Parkinson\u2019s disease. NPJ Parkinsons Dis 2:16021. https:\/\/doi.org\/10.1038\/npjparkd.2016.21","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"1708_CR11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.nrleng.2018.10.022","volume":"37","author":"S Garfias","year":"2022","unstructured":"Garfias S, Tamaya Dominguez B, Toledo Rojas A, Arroyo M, Rodriguez U, Boll C, Sosa AL, Sciutto E, Adalid-Peralta L, Martinez Lopez Y, Fragoso G, Fleury A (2022) Peripheral blood lymphocyte phenotypes in Alzheimer and Parkinson\u2019s diseases. Neurologia (Engl Ed) 37(2):110\u2013121. https:\/\/doi.org\/10.1016\/j.nrleng.2018.10.022","journal-title":"Neurologia (Engl Ed)"},{"issue":"1","key":"1708_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12974-021-02090-6","volume":"18","author":"P Gong","year":"2021","unstructured":"Gong P, Liu Y, Gong Y, Chen G, Zhang X, Wang S, Zhou F, Duan R, Chen W, Huang T, Wang M, Deng Q, Shi H, Zhou J, Jiang T, Zhang Y (2021) The association of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and lymphocyte to monocyte ratio with post-thrombolysis early neurological outcomes in patients with acute ischemic stroke. J Neuroinflammation 18(1):51. https:\/\/doi.org\/10.1186\/s12974-021-02090-6","journal-title":"J Neuroinflammation"},{"key":"1708_CR13","doi-asserted-by":"publisher","first-page":"105480","DOI":"10.1016\/j.parkreldis.2023.105480","volume":"112","author":"P Grillo","year":"2023","unstructured":"Grillo P, Sancesario GM, Bovenzi R, Zenuni H, Bissacco J, Mascioli D, Simonetta C, Forti P, Degoli GR, Pieri M, Chiurchiu V, Stefani A, Mercuri NB, Schirinzi T (2023) Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients. Parkinsonism Relat Disord 112:105480. https:\/\/doi.org\/10.1016\/j.parkreldis.2023.105480","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"1708_CR14","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s00401-014-1345-4","volume":"128","author":"V Grozdanov","year":"2014","unstructured":"Grozdanov V, Bliederhaeuser C, Ruf WP, Roth V, Fundel-Clemens K, Zondler L, Brenner D, Martin-Villalba A, Hengerer B, Kassubek J, Ludolph AC, Weishaupt JH, Danzer KM (2014) Inflammatory dysregulation of blood monocytes in Parkinson\u2019s disease patients. Acta Neuropathol 128(5):651\u2013663. https:\/\/doi.org\/10.1007\/s00401-014-1345-4","journal-title":"Acta Neuropathol"},{"issue":"1","key":"1708_CR15","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12883-023-03380-7","volume":"23","author":"S Hosseini","year":"2023","unstructured":"Hosseini S, Shafiabadi N, Khanzadeh M, Ghaedi A, Ghorbanzadeh R, Azarhomayoun A, Bazrgar A, Pezeshki J, Bazrafshan H, Khanzadeh S (2023) Neutrophil to lymphocyte ratio in parkinson\u2019s disease: a systematic review and meta-analysis. BMC Neurol 23(1):333. https:\/\/doi.org\/10.1186\/s12883-023-03380-7","journal-title":"BMC Neurol"},{"issue":"4","key":"1708_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00011-024-01861-0","volume":"73","author":"P Huang","year":"2024","unstructured":"Huang P, Mai Y, Zhao J, Yi Y, Wen Y (2024) Association of systemic immune-inflammation index and systemic inflammation response index with chronic kidney disease: observational study of 40,937 adults. Inflamm Res 73(4):655\u2013667. https:\/\/doi.org\/10.1007\/s00011-024-01861-0","journal-title":"Inflamm Res"},{"key":"1708_CR17","doi-asserted-by":"publisher","unstructured":"Jensen MP, Jacobs BM, Dobson R, Bandres-Ciga S, Blauwendraat C, Schrag A, Noyce AJ (2021) International Parkinson\u2019s disease genomics C lower lymphocyte count is associated with increased risk of Parkinson\u2019s disease. Ann Neurol 89 (4):803\u2013812. https:\/\/doi.org\/10.1002\/ana.26034","DOI":"10.1002\/ana.26034"},{"key":"1708_CR18","doi-asserted-by":"publisher","first-page":"1439803","DOI":"10.3389\/fnut.2024.1439803","volume":"11","author":"H Jia","year":"2024","unstructured":"Jia H, Yin K, Zhao J, Che F (2024) Association of inflammation\/nutrition-based indicators with Parkinson\u2019s disease and mortality. Front Nutr 11:1439803. https:\/\/doi.org\/10.3389\/fnut.2024.1439803","journal-title":"Front Nutr"},{"issue":"8","key":"1708_CR19","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1007\/s10072-017-2988-4","volume":"38","author":"S Jiang","year":"2017","unstructured":"Jiang S, Gao H, Luo Q, Wang P, Yang X (2017) The correlation of lymphocyte subsets, natural killer cell, and Parkinson\u2019s disease: a meta-analysis. Neurol Sci 38(8):1373\u20131380. https:\/\/doi.org\/10.1007\/s10072-017-2988-4","journal-title":"Neurol Sci"},{"issue":"3","key":"1708_CR20","doi-asserted-by":"publisher","first-page":"115382","DOI":"10.1016\/j.celrep.2025.115382","volume":"44","author":"OI Kahn","year":"2025","unstructured":"Kahn OI, Dominguez SL, Glock C, Hayne M, Vito S, Sengupta Ghosh A, Adrian M, Burgess BL, Meilandt WJ, Friedman BA, Hoogenraad CC (2025) Secreted neurofilament light chain after neuronal damage induces myeloid cell activation and neuroinflammation. Cell Rep 44(3):115382. https:\/\/doi.org\/10.1016\/j.celrep.2025.115382","journal-title":"Cell Rep"},{"issue":"9996","key":"1708_CR21","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912. https:\/\/doi.org\/10.1016\/S0140-6736(14)61393-3","journal-title":"Lancet"},{"issue":"12","key":"1708_CR22","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1136\/jnnp-2022-330394","volume":"94","author":"R Kim","year":"2023","unstructured":"Kim R, Kang N, Byun K, Park K, Jun JS (2023) Prognostic significance of peripheral neutrophils and lymphocytes in early untreated Parkinson\u2019s disease: an 8-year follow-up study. J Neurol Neurosurg Psychiatry 94(12):1040\u20131046. https:\/\/doi.org\/10.1136\/jnnp-2022-330394","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"1708_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/nan.12644","volume":"47","author":"P La Vitola","year":"2021","unstructured":"La Vitola P, Balducci C, Baroni M, Artioli L, Santamaria G, Castiglioni M, Cerovic M, Colombo L, Caldinelli L, Pollegioni L, Forloni G (2021) Peripheral inflammation exacerbates alpha-synuclein toxicity and neuropathology in Parkinson\u2019s models. Neuropathol Appl Neurobiol 47(1):43\u201360. https:\/\/doi.org\/10.1111\/nan.12644","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"10","key":"1708_CR24","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","volume":"46","author":"J Lauritsen","year":"2023","unstructured":"Lauritsen J, Romero-Ramos M (2023) The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component. Trends Neurosci 46(10):863\u2013878. https:\/\/doi.org\/10.1016\/j.tins.2023.07.005","journal-title":"Trends Neurosci"},{"key":"1708_CR25","doi-asserted-by":"publisher","first-page":"1322228","DOI":"10.3389\/fneur.2024.1322228","volume":"15","author":"F Li","year":"2024","unstructured":"Li F, Weng G, Zhou H, Zhang W, Deng B, Luo Y, Tao X, Deng M, Guo H, Zhu S, Wang Q (2024) The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson\u2019s disease. Front Neurol 15:1322228. https:\/\/doi.org\/10.3389\/fneur.2024.1322228","journal-title":"Front Neurol"},{"key":"1708_CR27","doi-asserted-by":"publisher","first-page":"635923","DOI":"10.1155\/2014\/635923","volume":"2014","author":"WC Lin","year":"2014","unstructured":"Lin WC, Tsai NW, Huang YC, Cheng KY, Chen HL, Li SH, Kung CT, Su YJ, Lin WM, Chen MH, Chiu TM, Yang IH, Lu CH (2014) Peripheral leukocyte apoptosis in patients with Parkinsonism: correlation with clinical characteristics and neuroimaging findings. Biomed Res Int 2014:635923. https:\/\/doi.org\/10.1155\/2014\/635923","journal-title":"Biomed Res Int"},{"issue":"1","key":"1708_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41531-025-00909-0","volume":"11","author":"R Lin","year":"2025","unstructured":"Lin R, Cai G, Chen Y, Zheng J, Wang S, Xiao H, Ye Q, Xue Y, Jiang R (2025) Association of glymphatic system function with peripheral inflammation and motor symptoms in Parkinson\u2019s disease. NPJ Parkinsons Dis 11(1):62. https:\/\/doi.org\/10.1038\/s41531-025-00909-0","journal-title":"NPJ Parkinsons Dis"},{"key":"1708_CR29","doi-asserted-by":"publisher","first-page":"911779","DOI":"10.3389\/fimmu.2022.911779","volume":"13","author":"Z Liu","year":"2022","unstructured":"Liu Z, Li Y, Wang Y, Zhang H, Lian Y, Cheng X (2022) The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with the severity of autoimmune encephalitis. Front Immunol 13:911779. https:\/\/doi.org\/10.3389\/fimmu.2022.911779","journal-title":"Front Immunol"},{"key":"1708_CR28","doi-asserted-by":"publisher","first-page":"1432401","DOI":"10.3389\/fneur.2024.1432401","volume":"15","author":"X Liu","year":"2024","unstructured":"Liu X, Yang Y, Lu Q, Yang J, Yuan J, Hu J, Tu Y (2024) Association between systemic immune-inflammation index and serum neurofilament light chain: a population-based study from the NHANES (2013\u20132014). Front Neurol 15:1432401. https:\/\/doi.org\/10.3389\/fneur.2024.1432401","journal-title":"Front Neurol"},{"key":"1708_CR30","doi-asserted-by":"publisher","unstructured":"Marogianni C, Sokratous M, Dardiotis E, Hadjigeorgiou GM, Bogdanos D, Xiromerisiou G (2020) Neurodegeneration and inflammation-an interesting interplay in Parkinson\u2019s disease. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21228421","DOI":"10.3390\/ijms21228421"},{"issue":"2","key":"1708_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JPD-202472","volume":"11","author":"TA Mestre","year":"2021","unstructured":"Mestre TA, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, Espay AJ, Halliday G, van Hilten JJ, Hu MT, Jeon B, Klein C, Leentjens AFG, Marinus J, Mollenhauer B, Postuma R, Rajalingam R, Rodriguez-Violante M, Simuni T, Surmeier DJ, Weintraub D, McDermott MP, Lawton M, Marras C (2021) Parkinson\u2019s disease subtypes: critical appraisal and recommendations. J Parkinsons Dis 11(2):395\u2013404. https:\/\/doi.org\/10.3233\/JPD-202472","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"1708_CR32","doi-asserted-by":"publisher","first-page":"e0305322","DOI":"10.1371\/journal.pone.0305322","volume":"19","author":"A Mohammadi","year":"2024","unstructured":"Mohammadi A, Mohammadi M, Almasi-Dooghaee M, Mirmosayyeb O (2024) Neutrophil to lymphocyte ratio in Alzheimer\u2019s disease: a systematic review and meta-analysis. PLoS ONE 19(6):e0305322. https:\/\/doi.org\/10.1371\/journal.pone.0305322","journal-title":"PLoS ONE"},{"issue":"19","key":"1708_CR33","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1212\/WNL.0000000000004609","volume":"89","author":"B Mollenhauer","year":"2017","unstructured":"Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Shaw LM, Trojanowski JQ, Singleton A, Frasier M, Marek K, Galasko D, Parkinson\u2019s Progression Marker I (2017) Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology 89(19):1959\u20131969. https:\/\/doi.org\/10.1212\/WNL.0000000000004609","journal-title":"Neurology"},{"issue":"10","key":"1708_CR35","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1002\/mds.28685","volume":"36","author":"L Munoz-Delgado","year":"2021","unstructured":"Munoz-Delgado L, Macias-Garcia D, Jesus S, Martin-Rodriguez JF, Labrador-Espinosa MA, Jimenez-Jaraba MV, Adarmes-Gomez A, Carrillo F, Mir P (2021) Peripheral immune profile and neutrophil-to-lymphocyte ratio in Parkinson\u2019s disease. Mov Disord 36(10):2426\u20132430. https:\/\/doi.org\/10.1002\/mds.28685","journal-title":"Mov Disord"},{"issue":"5","key":"1708_CR34","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/mds.29369","volume":"38","author":"L Munoz-Delgado","year":"2023","unstructured":"Munoz-Delgado L, Labrador-Espinosa MA, Macias-Garcia D, Jesus S, Benitez Zamora B, Fernandez-Rodriguez P, Adarmes-Gomez AD, Reina Castillo MI, Castro-Labrador S, Silva-Rodriguez J, Carrillo F, Garcia Solis D, Grothe MJ, Mir P (2023a) Peripheral Inflammation Is Associated with Dopaminergic Degeneration in Parkinson\u2019s Disease. Mov Disord 38(5):755\u2013763. https:\/\/doi.org\/10.1002\/mds.29369","journal-title":"Mov Disord"},{"issue":"1","key":"1708_CR36","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41531-023-00457-5","volume":"9","author":"L Munoz-Delgado","year":"2023","unstructured":"Munoz-Delgado L, Macias-Garcia D, Perinan MT, Jesus S, Adarmes-Gomez AD, Bonilla Toribio M, Buiza Rueda D, Jimenez-Jaraba MDV, Benitez Zamora B, Diaz Belloso R, Garcia-Diaz S, Martin-Bornez M, Pineda Sanchez R, Carrillo F, Gomez-Garre P, Mir P (2023b) Peripheral inflammatory immune response differs among sporadic and familial Parkinson\u2019s disease. NPJ Parkinsons Dis 9(1):12. https:\/\/doi.org\/10.1038\/s41531-023-00457-5","journal-title":"NPJ Parkinsons Dis"},{"issue":"11","key":"1708_CR37","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1002\/mds.27815","volume":"34","author":"SK Nissen","year":"2019","unstructured":"Nissen SK, Shrivastava K, Schulte C, Otzen DE, Goldeck D, Berg D, Moller HJ, Maetzler W, Romero-Ramos M (2019) Alterations in blood monocyte functions in Parkinson\u2019s disease. Mov Disord 34(11):1711\u20131721. https:\/\/doi.org\/10.1002\/mds.27815","journal-title":"Mov Disord"},{"issue":"3","key":"1708_CR38","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jamaneurol.2018.3746","volume":"76","author":"B Olsson","year":"2019","unstructured":"Olsson B, Portelius E, Cullen NC, Sandelius A, Zetterberg H, Andreasson U, Hoglund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, Toledo JB, McBride J, Hernandez-Con P, Lee VM, Trojanowski JQ, Blennow K (2019) Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders. JAMA Neurol 76(3):318\u2013325. https:\/\/doi.org\/10.1001\/jamaneurol.2018.3746","journal-title":"JAMA Neurol"},{"issue":"4","key":"1708_CR39","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"I Parkinson Progression Marker","year":"2011","unstructured":"Parkinson Progression Marker I (2011) The Parkinson progression marker initiative (PPMI). Prog Neurobiol 95(4):629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"issue":"12","key":"1708_CR40","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, Adler CH, Deuschl G (2015) MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov Disord 30(12):1591\u20131601. https:\/\/doi.org\/10.1002\/mds.26424","journal-title":"Mov Disord"},{"issue":"3","key":"1708_CR41","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1515\/RNS.2011.028","volume":"22","author":"KD Prajapati","year":"2011","unstructured":"Prajapati KD, Sharma SS, Roy N (2011) Current perspectives on potential role of albumin in neuroprotection. Rev Neurosci 22(3):355\u2013363. https:\/\/doi.org\/10.1515\/RNS.2011.028","journal-title":"Rev Neurosci"},{"issue":"13","key":"1708_CR42","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","volume":"29","author":"T Pringsheim","year":"2014","unstructured":"Pringsheim T, Jette N, Frolkis A, Steeves TD (2014) The prevalence of Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 29(13):1583\u20131590. https:\/\/doi.org\/10.1002\/mds.25945","journal-title":"Mov Disord"},{"issue":"5","key":"1708_CR43","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.14336\/AD.2019.0112","volume":"10","author":"E Qian","year":"2019","unstructured":"Qian E, Huang Y (2019) Subtyping of Parkinson\u2019s disease - Where Are We Up To? Aging Dis 10(5):1130\u20131139. https:\/\/doi.org\/10.14336\/AD.2019.0112","journal-title":"Aging Dis"},{"key":"1708_CR44","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.parkreldis.2016.04.027","volume":"28","author":"T Simuni","year":"2016","unstructured":"Simuni T, Caspell-Garcia C, Coffey C, Lasch S, Tanner C, Marek K, Investigators P (2016) How stable are Parkinson\u2019s disease subtypes in de novo patients: analysis of the PPMI cohort? Parkinsonism Relat Disord 28:62\u201367. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.04.027","journal-title":"Parkinsonism Relat Disord"},{"key":"1708_CR45","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su D, Cui Y, He C, Yin P, Bai R, Zhu J, Lam JST, Zhang J, Yan R, Zheng X, Wu J, Zhao D, Wang A, Zhou M, Feng T (2025) Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021. BMJ 388:e080952. https:\/\/doi.org\/10.1136\/bmj-2024-080952","journal-title":"BMJ"},{"issue":"37","key":"1708_CR46","doi-asserted-by":"publisher","first-page":"e30324","DOI":"10.1097\/MD.0000000000030324","volume":"101","author":"S Sun","year":"2022","unstructured":"Sun S, Wen Y, Li Y (2022) Serum albumin, cognitive function, motor impairment, and survival prognosis in Parkinson disease. Med (Baltim) 101(37):e30324. https:\/\/doi.org\/10.1097\/MD.0000000000030324","journal-title":"Med (Baltim)"},{"issue":"3","key":"1708_CR47","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/ejn.14290","volume":"49","author":"MG Tansey","year":"2019","unstructured":"Tansey MG, Romero-Ramos M (2019) Immune system responses in Parkinson\u2019s disease: early and dynamic. Eur J Neurosci 49(3):364\u2013383. https:\/\/doi.org\/10.1111\/ejn.14290","journal-title":"Eur J Neurosci"},{"issue":"11","key":"1708_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V (2022) Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol 22(11):657\u2013673. https:\/\/doi.org\/10.1038\/s41577-022-00684-6","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1708_CR49","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","volume":"20","author":"E Tolosa","year":"2021","unstructured":"Tolosa E, Garrido A, Scholz SW, Poewe W (2021) Challenges in the diagnosis of Parkinson\u2019s disease. Lancet Neurol 20(5):385\u2013397. https:\/\/doi.org\/10.1016\/S1474-4422(21)00030-2","journal-title":"Lancet Neurol"},{"key":"1708_CR51","doi-asserted-by":"publisher","first-page":"1115031","DOI":"10.3389\/fimmu.2023.1115031","volume":"14","author":"RH Wang","year":"2023","unstructured":"Wang RH, Wen WX, Jiang ZP, Du ZP, Ma ZH, Lu AL, Li HP, Yuan F, Wu SB, Guo JW, Cai YF, Huang Y, Wang LX, Lu HJ (2023) The clinical value of neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), platelet-to-lymphocyte ratio (PLR) and systemic inflammation response index (SIRI) for predicting the occurrence and severity of pneumonia in patients with intracerebral hemorrhage. Front Immunol 14:1115031. https:\/\/doi.org\/10.3389\/fimmu.2023.1115031","journal-title":"Front Immunol"},{"key":"1708_CR50","doi-asserted-by":"publisher","unstructured":"Wang H, Li W, Lai Q, Huang Q, Ding H, Deng Z (2024) Inflammatory markers and risk of Parkinson\u2019s disease: a population-based analysis. Parkinsons Dis 2024(4192853). https:\/\/doi.org\/10.1155\/padi\/4192853","DOI":"10.1155\/padi\/4192853"},{"issue":"3","key":"1708_CR52","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mds.23469","volume":"26","author":"MM Wickremaratchi","year":"2011","unstructured":"Wickremaratchi MM, Knipe MD, Sastry BS, Morgan E, Jones A, Salmon R, Weiser R, Moran M, Davies D, Ebenezer L, Raha S, Robertson NP, Butler CC, Ben-Shlomo Y, Morris HR (2011) The motor phenotype of Parkinson\u2019s disease in relation to age at onset. Mov Disord 26(3):457\u2013463. https:\/\/doi.org\/10.1002\/mds.23469","journal-title":"Mov Disord"},{"issue":"s1","key":"1708_CR53","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.3233\/JPD-223241","volume":"12","author":"GP Williams","year":"2022","unstructured":"Williams GP, Schonhoff AM, Sette A, Lindestam Arlehamn CS (2022) Central and peripheral inflammation: connecting the immune responses of Parkinson\u2019s disease. J Parkinsons Dis 12(s1):S129\u2013S136. https:\/\/doi.org\/10.3233\/JPD-223241","journal-title":"J Parkinsons Dis"},{"key":"1708_CR54","doi-asserted-by":"publisher","unstructured":"Xiao Y, Ma Y, Shang H (2025) Association of neutrophil-to-lymphocyte ratio with incidence and disease progression in Parkinson\u2019s disease. Neuroepidemiology. https:\/\/doi.org\/10.1159\/000545314","DOI":"10.1159\/000545314"},{"key":"1708_CR55","doi-asserted-by":"publisher","first-page":"582825","DOI":"10.3389\/fimmu.2020.582825","volume":"11","author":"Q Yang","year":"2020","unstructured":"Yang Q, Wang G, Zhang F (2020) Role of peripheral immune cells-mediated inflammation on the process of neurodegenerative diseases. Front Immunol 11:582825. https:\/\/doi.org\/10.3389\/fimmu.2020.582825","journal-title":"Front Immunol"},{"key":"1708_CR56","doi-asserted-by":"publisher","first-page":"1529197","DOI":"10.3389\/fnagi.2025.1529197","volume":"17","author":"J Zhao","year":"2025","unstructured":"Zhao J, Wu Z, Cai F, Yu X, Song Z (2025) Higher systemic immune-inflammation index is associated with increased risk of Parkinson\u2019s disease in adults: a nationwide population-based study. Front Aging Neurosci 17:1529197. https:\/\/doi.org\/10.3389\/fnagi.2025.1529197","journal-title":"Front Aging Neurosci"},{"key":"1708_CR57","doi-asserted-by":"publisher","unstructured":"Zhou Q, Jia R, Dang J (2022) Correlation between the neutrophil-to-lymphocyte ratio and multiple sclerosis: recent understanding and potential application perspectives. Neurol Res Int. https:\/\/doi.org\/10.1155\/2022\/3265029","DOI":"10.1155\/2022\/3265029"},{"key":"1708_CR58","doi-asserted-by":"publisher","first-page":"107305","DOI":"10.1016\/j.parkreldis.2025.107305","volume":"133","author":"W Zhou","year":"2025","unstructured":"Zhou W, Xia Q, Liu D, Li JY, Gong L (2025) The HALP score differs among sporadic and familial Parkinson\u2019s disease. Parkinsonism Relat Disord 133:107305. https:\/\/doi.org\/10.1016\/j.parkreldis.2025.107305","journal-title":"Parkinsonism Relat Disord"},{"key":"1708_CR59","doi-asserted-by":"publisher","unstructured":"Zinellu A, Paliogiannis P, Mangoni AA (2023) Aggregate Index of Systemic Inflammation (AISI), disease severity, and mortality in COVID-19: a systematic review and meta-analysis. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12144584","DOI":"10.3390\/jcm12144584"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10571-026-01708-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01708-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-026-01708-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T18:02:50Z","timestamp":1774288970000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10571-026-01708-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,8]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1708"],"URL":"https:\/\/doi.org\/10.1007\/s10571-026-01708-8","relation":{},"ISSN":["1573-6830"],"issn-type":[{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,8]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}],"article-number":"73"}}